Clinical characteristics of MASLD/MetALD/MAFLD/NAFLD and the relative risk analysis on metabolic disorders
The proposed definitions of MASLD and MetALD are valuable and deserve further exploration. Our findings suggest that MAFLD is a more effective indicator for identifying patients at increased risk for metabolic disorders.
Authors
- Wenliang Lv (ORCID: https://orcid.org/0000-0002-4552-919X)
- Yanping Lu (ORCID: https://orcid.org/0000-0002-0465-7881)
- Xiaoqiang Huang (ORCID: https://orcid.org/0000-0002-1005-848X)
- Hao Yang Peng (ORCID: https://orcid.org/0000-0001-6277-662X)
- Chun-li Lu (ORCID: https://orcid.org/0000-0003-2939-1327)
- Zhenjian Zhuo (ORCID: https://orcid.org/0000-0003-0142-4086)
- Shuxia Huang
- Mo Zhao
- Jing Liu (ORCID: https://orcid.org/0000-0002-3255-3019)
Institutions
- Beijing University of Chinese Medicine (CN)
- Guangdong Pharmaceutical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Guang’anmen Hospital (CN)
Publication Details
- Journal
- BMC Gastroenterology
- Published
- 2025-05-14
- DOI
- https://doi.org/10.1186/s12876-025-03912-0
- Citations
- 4
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.42
Funders
- National Natural Science Foundation of China